Chiesi announced that the company has signed an agreement with Koura (formerly Mexichem) for supply of HFA 152a propellant as part of a €350 million plan to bring a pMDI with a 90% lower carbon footprint to market by the end of 2025. The company, which has also pledged that it would be carbon neutral by 2035, made the announcement at the Nations Climate Change … [Read more...] about Chiesi announces plans for lower carbon footprint HFA 152a inhaler by the end of 2025
Products and Services
Lupin launches Adhero inhaler monitoring device in India
Lupin has launched its new Adhero connected inhaler monitoring device in India, the company said. According to Lupin, the company collaborated with Aptar Pharma on the device, which attaches to the tops of MDIs. The Adhero sensors allow for monitoring of inhaler use, and data are uploaded to a "MyAdhero" app via Bluetooth. The usage data are also accessible to … [Read more...] about Lupin launches Adhero inhaler monitoring device in India
Hovione Technology completes pilot scale manufacturing for Papillon DPI blisters
Hovione Technology said that the company has completed pilot-scale blister manufacturing and filling for its Papillon dry powder inhaler. The company announced in April 2019 that it had acquired the rights to the DPI from its inventor, Klaus-Dieter Beller. The Papillon DPI, which is formed from a single plastic part and is reusable, can hold doses of up to 50 mg … [Read more...] about Hovione Technology completes pilot scale manufacturing for Papillon DPI blisters
Recipharm to acquire Consort Medical
Swedish CDMO Recipharm has announced that it will acquire Consort Medical, the parent company of device maker Bespak and CDMO Aesica, in order to "Become a Leading Inhalation Company and Top Five Global CDMO Player." According to Recipharm, the companies have agreed on a cash offer of £505 million. In the past few years, Recipharm has aggressively expanded its … [Read more...] about Recipharm to acquire Consort Medical
Biocorp announces deal with Vitrobio for manufacturing of intranasal product
French drug delivery device company Biocorp announced that it has entered into a 10-year strategic partnership with Vitrobio Pharma regarding manufacturing of a new intranasal polymeric product that the company says "acts as a barrier on the nasal surface and prevents contact with pollutants and allergens, while eliminating histamines and harmful proteins through … [Read more...] about Biocorp announces deal with Vitrobio for manufacturing of intranasal product
Inhaler sensor company Adherium gets $1.1 million in new financing round
According to Adherium, the company has received $1.1 million in a second round of secured debt note financing, and the subscriber for this round is new strategic investor Trudell Medical Limited, parent company of respiratory device companies Trudell Medical International, Monaghan Medical, and NasoNeb. Adherium said that the funds would be used for working … [Read more...] about Inhaler sensor company Adherium gets $1.1 million in new financing round
Iconovo and Crystec sign collaboration agreement for DPI development
Device maker Iconovo and particle engineering specialist CrystecPharma have announced a non-exclusive collaboration agreement for development of dry powder inhalers. The companies say that they plan to develop engineered particles using CrystecPharma's modified supercritical anti-solvent (mSAS) technology for delivery via one of Iconovo's devices. According to the … [Read more...] about Iconovo and Crystec sign collaboration agreement for DPI development
Aptar acquires training device company Noble International
Aptar has announced its acquisition of Noble International, which specializes in training devices and patient onboarding for drug delivery devices, including inhalers. Noble makes respiratory trainers for both MDIs and DPIs with a variety of technologies including Bluetooth connectivity, actuation force simulation, and error detection/correction. According to … [Read more...] about Aptar acquires training device company Noble International
Micro-Sphere to add spray drying capacity
CDMO Micro-Sphere has announced an investment of 3.5 million CHF (~$3.5 million) that will include the addition of a fifth spray drying line to its GMP facility in Switzerland. The new line should be in operation by the first quarter of 2021. According to the company, the expansion is needed due to increased demand for both spray drying and capsule filling for DPIs. … [Read more...] about Micro-Sphere to add spray drying capacity
Iconovo to develop generic Ellipta DPI platform
Dry powder inhaler developer Iconovo has announced that the company will invest approximately 20 million SEK over about 3 years to develop a new platform for development of generic versions of Ellipta DPI products. The platform will include a new device called ICOpre and custom dry powder formulations that will be pre-filled. The company said that the generic … [Read more...] about Iconovo to develop generic Ellipta DPI platform